phosphoric acid, trisodium salt and Adverse Drug Event

phosphoric acid, trisodium salt has been researched along with Adverse Drug Event in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (50.00)	29.6817
2010's	2 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Caswell, M	1
Nagami, GT; Paige, NM	1
O'Connor, NR	1
Demir, M; Gokturk, HS; Gur, G; Ozturk, NA; Unler, GK; Yilmaz, U	1

Reviews

1 review(s) available for phosphoric acid, trisodium salt and Adverse Drug Event

Article	Year
FDA boxed warnings: how to prescribe drugs safely. American family physician, 2010, Feb-01, Volume: 81, Issue:3 Topics: Albuterol; Anti-Bacterial Agents; Bronchodilator Agents; Drug Approval; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Fluoroquinolones; Humans; Phosphates; Prescription Drugs; Salmeterol Xinafoate; United States; United States Food and Drug Administration	2010

Trials

1 trial(s) available for phosphoric acid, trisodium salt and Adverse Drug Event

Article	Year
Efficacy and safety of sodium phosphate for colon cleansing in type 2 diabetes mellitus. Southern medical journal, 2010, Volume: 103, Issue:11 Topics: Cathartics; Colonoscopy; Diabetes Mellitus, Type 2; Drug-Related Side Effects and Adverse Reactions; Female; Glycated Hemoglobin; Humans; Male; Matched-Pair Analysis; Middle Aged; Phosphates	2010

Other Studies

2 other study(ies) available for phosphoric acid, trisodium salt and Adverse Drug Event

Article	Year
No black box on phosphosoda. Archives of internal medicine, 2008, Nov-10, Volume: 168, Issue:20 Topics: Cathartics; Drug-Related Side Effects and Adverse Reactions; Phosphates; United States; United States Food and Drug Administration	2008
The top 10 things nephrologists wish every primary care physician knew. Mayo Clinic proceedings, 2009, Volume: 84, Issue:2 Topics: Aluminum; Anemia; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antacids; Blood Pressure; Blood Urea Nitrogen; Cardiovascular Diseases; Cathartics; Chronic Disease; Contraindications; Creatinine; Cyclosporine; Disease Progression; Drug Interactions; Drug-Related Side Effects and Adverse Reactions; Erythropoietin; Evidence-Based Medicine; Glomerular Filtration Rate; Humans; Hypertension; Immunosuppressive Agents; Kidney Diseases; Magnesium; Nephrolithiasis; Nephrology; Phosphates; Primary Health Care; Proteinuria; Recombinant Proteins; Referral and Consultation; Tacrolimus; Urinalysis	2009

Article

Year

No black box on phosphosoda.

Archives of internal medicine, 2008, Nov-10, Volume: 168, Issue:20

Topics: Cathartics; Drug-Related Side Effects and Adverse Reactions; Phosphates; United States; United States Food and Drug Administration

2008

The top 10 things nephrologists wish every primary care physician knew.

Mayo Clinic proceedings, 2009, Volume: 84, Issue:2

Topics: Aluminum; Anemia; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antacids; Blood Pressure; Blood Urea Nitrogen; Cardiovascular Diseases; Cathartics; Chronic Disease; Contraindications; Creatinine; Cyclosporine; Disease Progression; Drug Interactions; Drug-Related Side Effects and Adverse Reactions; Erythropoietin; Evidence-Based Medicine; Glomerular Filtration Rate; Humans; Hypertension; Immunosuppressive Agents; Kidney Diseases; Magnesium; Nephrolithiasis; Nephrology; Phosphates; Primary Health Care; Proteinuria; Recombinant Proteins; Referral and Consultation; Tacrolimus; Urinalysis

2009